Harnessing immu
Harnessing the Immune System to Fight Cancer http://nyti.ms/2ap8pHr
Comments
-
oops! Pressed posr by mistake on my phone without my glasses. Ugh.
-
And here I was thinking there was some exotic new natural therapy called immu.
-
Interesting article. Thanks for posting. I do believe immunotherapy is the way to our future. I wish they would hurry up and figure it out.
-
Very interesting indeed. It does inspire some hope in me, but like Kandy says "Time is of the essence". I pray for an absolute explosion of progress very soon for MBC and every cancer.
-
FYI: Immunotherapy for Breast Cancer topic at bco –
-
thanks, stephanie!
-
Very good and thorough piece on checkpoint inhibitors. Recently, there was an interview with Dr. Vincent DaVita on OncLive - author of The Death Of Cancer, and he stated that checkpoint inhibitors are going to one of the three greatest breakthroughs in cancer treatment. But he did think - like so many cancer therapies, it will be most effective when used in combination with other therapies. And there are so many new therapies in development.
-
great article! Thanks for sharing.I'm in an immunotherapy trial for one of the checkpoint inhibitors and passed this on to friends and family. It's a great explanation of the potential and why I was willing to go through so much to get in.
I've only finished the first cycle and don't know if in recieving the trial drug (atezolizumab ) or placebo, but I've had side effect reasons to believe it's the immu drug.
-
Here's another great link pwilmarth posted today....Setting the Body's 'Serial Killers' Loose on Cancer
-
Another interesting, related story:
In cancer, it's back to the future as old treatments make cutting-edge ones more effective
SHARON BEGLEY
AUGUST 4, 2016
New cancer drugs that unleash the immune system on tumors are all the rage, getting credit for curing former President Jimmy Carter's advanced melanoma and inspiring tech billionaire Sean Parker to pledge $250 million to cancer research. Behind the excitement, however, is the hard truth that these therapies work in only a minority of patients.
Now scientists are finding hints of a solution in an unexpected place: Older, out-of-favor cancer treatments such as chemotherapy and radiation may make the cutting-edge immune-based drugs effective against more cancers — even hard-to-treat ovarian and pancreatic tumors.
The growing body of research raises the possibility that it might not be necessary to invent new medications to make meaningful progress against cancer. "If we just take the drugs we have and combine them in the right way, I think there is huge potential" for beating more cancers into remission, said Dr. Patrick Hwu of M.D. Anderson Cancer Center in Houston.
If early successes pan out in animal experiments and dozens of clinical trials now underway, patients would have more options and a better chance at a true cure. Another plus: radiation and generic chemotherapy are relatively cheap compared with new immuno-oncology medicines.
Tumors disable the immune system's killer T cells, which can find and destroy certain cancer cells. Immunotherapy drugs work by preventing tumors from using this devious tactic. But if no T cells are swarming the tumor in the first place, the drugs don't help. It's like playing the San Antonio Spurs with NBA defensive player of the year Kawhi Leonard sitting on the bench, but then not getting your own players past midcourt.
The trick, therefore, is to turn "cold" tumors that T cells ignore into "hot" tumors that attract T cells. Or, at the risk of torturing the metaphor, to get those T cells past midcourt. "If the T cells don't exist, the question is, how do you make them exist?" said Hwu.
Continued at:
https://www.statnews.com/2016/08/04/combination-cancer-treatments/
-
I should read the article, but I don't understand what that means, when it says "Tumors disable T cells." How would they do that?
-
One of the tricks they are using to get T-Cells to work is to use a genetically altered virus, like Polio, which does stimulate the immune system to attack the cancer cells. They have had amazing results with this strategy at Duke University with a rare form of brain cancer and there are plans to expand this strategy to other solid tumors.
The study at Duke was a Phase I trial, which means they are still working out the safest dose of the virus to give. Too much creates an over stimulation of the immune system with adverse effects they need to manage. So they cut the dose, and get incomplete results. However, it appears that the cancer is weakened and is then more susceptible to standard chemotherapy.
This gets back to the opinion of Dr. DaVita. His experience in treating cancer is that nearly every agent they use is more effective when used in combination with other treatments. The purpose of clinical trials is to investigate the best way to use these agents in combination to produce good outcomes.
-
Ninetwelve, I am with you that this subject can be highly technical and confusing. When i read these articles I basically skim over the too complicated parts and get what I can from the rest, which is always something. Plus, the more I read these the easier it gets to comprehend. (To a point! hahaha)
-
Having done a vaccine trial at Fred Hutch in Seattle for Her2+++ patients, I feel they are on to something in kick starting the immune system (T cells) to recognize the cancer cells as "invaders". During the trial my immune system went into hyper drive. Being allergic to bee stings can be a problem for a bee keeper, LOL! I show allergic reactions to crab, insects, many pollens. These reactions were not present before the trial. I am hoping the cancer cells are included in those my body has decided to attack. I have been NED now for 5 years, ever since participating in the trial. At what point can I convince them that this was successful? (I continue on Tykerb and Herceptin treatments, as the oncologists will not say "cure".) My oncologist told me that I will continue on Herceptin infusions every three weeks, and Tykerb daily, until I die. And I laughed and told him that I would see him retire as I continue treatments in 20-30 years.
As a side discussion, my brother has lymphoma. Enduring 5 stem cell transplants, being near death many times, he is doing well. He was the very first patient at Fred Hutch and Seattle Cancer Care to undergo CAR-T cell transplant. (Removing the patients own T cells and training them to recognize the cancer cells. He said after the cells were re infused that it felt like his tumors were melting like sticks of butter in the summer sun.)
My brother and I were diagnosed within weeks of each other (he is one year younger than I). He with a rare, aggressive lymphoma. Me with a rare aggressive breast cancer (Inflammatory Breast Cancer). Both Stage IV, both given weeks to live in 2009. We are both in "remission?" after immune system trials.
-
Ninetwelve - normal cells have a certain molecule on the surface that is there to tell the immune system that they are normal cells. Some cancer expresses that receptor. It's like the cancer cells know the secret handshake that normal cells give to T-Cells. The receptor is called pi3K and they have developed pi3K inhibitors to bind with that receptor on cancer cells. With that receptor disabled the T-Cells will attack the cancer.
pi3K receptors are part of the mTOR pathway, so this class of drug is also called mTOR inhibitors. Afinitor was the first FDA approved mTOR inhibitor.
That said, the science we get in these articles is quite simplified. There are a lot of problems with the model and mechanisms if you dig into it. They used to think that breast cancer that did not express pi3K receptors would not respond to pi3K inhibitors but they do. If you block pi3K inhibitors, doesn't the body attack all normal cells with pi3K inhibitors? It turns out that the body does attack normal cells with pi3K inhibitors and sometimes you will get a massive auto-immune response.
Afinitor can have very hard side effects. Some of the newer pi3K inhibitors do attack the cancer with almost no side effects. But only in some people. The science is more complicated than presented. They also don't completely understand how these drugs work.
I may be a biology and a chemistry class ahead of you, but I basically do what Artist does. It's still very interesting to follow. There is no reason to feel you need to completely understand it because when you dig into it, the science behind these drugs is not completely understood.
This is one reason I am not fond of being talked down to by people in white coats who will only prescribe "clinically proven" drugs. When you look at the history of clinically proven drugs, they don't completely understand how they work and what they can and cannot do for years, if ever.
>Z<
Categories
- All Categories
- 679 Advocacy and Fund-Raising
- 289 Advocacy
- 68 I've Donated to Breastcancer.org in honor of....
- Test
- 322 Walks, Runs and Fundraising Events for Breastcancer.org
- 5.6K Community Connections
- 282 Middle Age 40-60(ish) Years Old With Breast Cancer
- 53 Australians and New Zealanders Affected by Breast Cancer
- 208 Black Women or Men With Breast Cancer
- 684 Canadians Affected by Breast Cancer
- 1.5K Caring for Someone with Breast cancer
- 455 Caring for Someone with Stage IV or Mets
- 260 High Risk of Recurrence or Second Breast Cancer
- 22 International, Non-English Speakers With Breast Cancer
- 16 Latinas/Hispanics With Breast Cancer
- 189 LGBTQA+ With Breast Cancer
- 152 May Their Memory Live On
- 85 Member Matchup & Virtual Support Meetups
- 375 Members by Location
- 291 Older Than 60 Years Old With Breast Cancer
- 177 Singles With Breast Cancer
- 869 Young With Breast Cancer
- 50.4K Connecting With Others Who Have a Similar Diagnosis
- 204 Breast Cancer with Another Diagnosis or Comorbidity
- 4K DCIS (Ductal Carcinoma In Situ)
- 79 DCIS plus HER2-positive Microinvasion
- 529 Genetic Testing
- 2.2K HER2+ (Positive) Breast Cancer
- 1.5K IBC (Inflammatory Breast Cancer)
- 3.4K IDC (Invasive Ductal Carcinoma)
- 1.5K ILC (Invasive Lobular Carcinoma)
- 999 Just Diagnosed With a Recurrence or Metastasis
- 652 LCIS (Lobular Carcinoma In Situ)
- 193 Less Common Types of Breast Cancer
- 252 Male Breast Cancer
- 86 Mixed Type Breast Cancer
- 3.1K Not Diagnosed With a Recurrence or Metastases but Concerned
- 189 Palliative Therapy/Hospice Care
- 488 Second or Third Breast Cancer
- 1.2K Stage I Breast Cancer
- 313 Stage II Breast Cancer
- 3.8K Stage III Breast Cancer
- 2.5K Triple-Negative Breast Cancer
- 13.1K Day-to-Day Matters
- 132 All things COVID-19 or coronavirus
- 87 BCO Free-Cycle: Give or Trade Items Related to Breast Cancer
- 5.9K Clinical Trials, Research News, Podcasts, and Study Results
- 86 Coping with Holidays, Special Days and Anniversaries
- 828 Employment, Insurance, and Other Financial Issues
- 101 Family and Family Planning Matters
- Family Issues for Those Who Have Breast Cancer
- 26 Furry friends
- 1.8K Humor and Games
- 1.6K Mental Health: Because Cancer Doesn't Just Affect Your Breasts
- 706 Recipe Swap for Healthy Living
- 704 Recommend Your Resources
- 171 Sex & Relationship Matters
- 9 The Political Corner
- 874 Working on Your Fitness
- 4.5K Moving On & Finding Inspiration After Breast Cancer
- 394 Bonded by Breast Cancer
- 3.1K Life After Breast Cancer
- 806 Prayers and Spiritual Support
- 285 Who or What Inspires You?
- 28.7K Not Diagnosed But Concerned
- 1K Benign Breast Conditions
- 2.3K High Risk for Breast Cancer
- 18K Not Diagnosed But Worried
- 7.4K Waiting for Test Results
- 603 Site News and Announcements
- 560 Comments, Suggestions, Feature Requests
- 39 Mod Announcements, Breastcancer.org News, Blog Entries, Podcasts
- 4 Survey, Interview and Participant Requests: Need your Help!
- 61.9K Tests, Treatments & Side Effects
- 586 Alternative Medicine
- 255 Bone Health and Bone Loss
- 11.4K Breast Reconstruction
- 7.9K Chemotherapy - Before, During, and After
- 2.7K Complementary and Holistic Medicine and Treatment
- 775 Diagnosed and Waiting for Test Results
- 7.8K Hormonal Therapy - Before, During, and After
- 50 Immunotherapy - Before, During, and After
- 7.4K Just Diagnosed
- 1.4K Living Without Reconstruction After a Mastectomy
- 5.2K Lymphedema
- 3.6K Managing Side Effects of Breast Cancer and Its Treatment
- 591 Pain
- 3.9K Radiation Therapy - Before, During, and After
- 8.4K Surgery - Before, During, and After
- 109 Welcome to Breastcancer.org
- 98 Acknowledging and honoring our Community
- 11 Info & Resources for New Patients & Members From the Team